PD-L1 Senescent Macrophages Reshape the Immune Microenvironment of Periodontitis via PI3K/AKT Pathway Activation.
[OBJECTIVE] To investigate the senescence/apoptosis phenotype of PD-L1 macrophages in gingival tissues with periodontitis and their relationship with the PI3K/AKT pathway.
APA
Ren S, Mo H, et al. (2026). PD-L1 Senescent Macrophages Reshape the Immune Microenvironment of Periodontitis via PI3K/AKT Pathway Activation.. Oral diseases. https://doi.org/10.1111/odi.70337
MLA
Ren S, et al.. "PD-L1 Senescent Macrophages Reshape the Immune Microenvironment of Periodontitis via PI3K/AKT Pathway Activation.." Oral diseases, 2026.
PMID
41955619
Abstract
[OBJECTIVE] To investigate the senescence/apoptosis phenotype of PD-L1 macrophages in gingival tissues with periodontitis and their relationship with the PI3K/AKT pathway.
[METHODS] Immunohistochemistry and multiplex immunofluorescence were used to assess PD-L1 expression and its colocalization with CD68/CD163 and p21 in human periodontitis gingival tissues. Public single-cell and bulk transcriptomic datasets were integrated to characterize PD-L1 macrophages. RAW264.7 senescence models were induced separately with Porphyromonas gingivalis LPS or HO, followed by lentiviral shRNA knockdown of PD-L1 to evaluate SASP, apoptosis-related markers, and PI3K/AKT signaling.
[RESULTS] PD-L1 was markedly upregulated in periodontitis gingiva and enriched in p21 macrophages. Single-cell and bulk analyses showed expansion of PD-L1 macrophages accompanied by upregulation of CDKN1A/CDKN2A and SASP factors such as IL-6 and IL-1β, increased expression of BCL2 family members, and activation of PI3K/AKT signaling. In the in vitro senescence model, PD-L1, p-PI3K, and p-AKT were elevated, and cells exhibited resistance to apoptosis. PD-L1 knockdown reduced PI3K/AKT activity, alleviated senescence and SASP, and promoted apoptosis.
[CONCLUSION] In periodontitis, PD-L1 senescent macrophages maintain inflammatory amplification and resistance to apoptosis through activation of the PI3K/AKT pathway. The PD-L1/PI3K/AKT axis may represent a potential immunomodulatory target for periodontitis treatment.
[METHODS] Immunohistochemistry and multiplex immunofluorescence were used to assess PD-L1 expression and its colocalization with CD68/CD163 and p21 in human periodontitis gingival tissues. Public single-cell and bulk transcriptomic datasets were integrated to characterize PD-L1 macrophages. RAW264.7 senescence models were induced separately with Porphyromonas gingivalis LPS or HO, followed by lentiviral shRNA knockdown of PD-L1 to evaluate SASP, apoptosis-related markers, and PI3K/AKT signaling.
[RESULTS] PD-L1 was markedly upregulated in periodontitis gingiva and enriched in p21 macrophages. Single-cell and bulk analyses showed expansion of PD-L1 macrophages accompanied by upregulation of CDKN1A/CDKN2A and SASP factors such as IL-6 and IL-1β, increased expression of BCL2 family members, and activation of PI3K/AKT signaling. In the in vitro senescence model, PD-L1, p-PI3K, and p-AKT were elevated, and cells exhibited resistance to apoptosis. PD-L1 knockdown reduced PI3K/AKT activity, alleviated senescence and SASP, and promoted apoptosis.
[CONCLUSION] In periodontitis, PD-L1 senescent macrophages maintain inflammatory amplification and resistance to apoptosis through activation of the PI3K/AKT pathway. The PD-L1/PI3K/AKT axis may represent a potential immunomodulatory target for periodontitis treatment.
같은 제1저자의 인용 많은 논문 (5)
- Defining success in functional cure for chronic hepatitis B: a nationwide survey of physician benchmarks to guide clinical practice and trial design.
- Patient-Reported Symptom and Symptom Clusters During Immune Checkpoint Inhibitor Therapy for Cancer Patients: A Cross-Sectional Survey.
- Case report: endocarditis or catheter-related right atrial thrombosis in a patient undergoing chemotherapy for Hodgkin lymphoma: diagnostic challenges and therapeutic dilemmas.
- Crizotinib-induced hyperlipidemia in advanced lung adenocarcinoma: A case report and literature review.
- Regulating arachidonic acid metabolism: a novel strategy to prevent colorectal inflammatory cancer transformation.